Urgent: Hydroxycut Lawsuits Have Recently Been Reported
On May 1, 2009, there had been a recall of 14 Hydroxycut diet-aid products stemming from a number of reports that folks using the products were developing significant liver issues and other health worries. Less than a week later, on May 4, the first Hydroxycut class action suit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Lawsuit alleges company negligence in informing the public about potential hazards of the products. Naturally, it’s too shortly to understand the suit is going to turn out, but if the company had information which it did not reveal to consumers, it should definitely be held accountable.
A class action lawsuit is filed by a bunch of people, all of whom have similar claims against a certain company. Filing a class action is just as effective, and much less pricey, than filing an individual suit. As a rule, filing a class action court action will not cost you anything unless there is a settlement. At that time, the attorney who handled the suit will take his costs from the compensation that was given and then share the leftover funds to the accusers in the case. Since this is the case, you will be able to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is an example of the reasons that class action legal actions became so popular.
The initial class action legal action against Iovate was filed in Canada where the company is located and represents all Canadian voters who sustained health issues due to Hydroxycut products. The FDA recall happened in the U. S. where 23 cases of liver disorders and other health problems had been reported. Health Canada failed to receive any reports of liver damage due to the diet products, but they did receive seventeen reports concerning people who sustained respiratory, neurological, heart, and stomach problems as a result of Canadians using the products.
The Hydroxycut Lawsuit alleges the company sold the products without correctly informing the general public of the public of the health risks that they could exposing buyers to. The complaint states the company failed to publish the data on the product labels stating that users could run the chance of liver and kidney damage as well as stomach, cardio, respiration, and neurological problems. The suit goes on to claim this was a blatant omission on the part of the company which deliberately misled clients concerning the protection of the products.
